12/19/2024
3:43 PM | Mellon James (Filed by)
Portage Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/17/2024
6:05 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024
6:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024
3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024
3:15 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024
4:01 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/12/2024
3:30 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
12/05/2024
3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/05/2024
3:28 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
3:47 PM | Portage Biotech (Filer)
| Form 424B3 | |
11/26/2024
3:25 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
3:26 PM | ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
| Form SC 13G/A | |
10/04/2024
3:30 PM | Portage Biotech (Filer)
| Form 424B3 | |
10/04/2024
3:15 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024
8:18 PM | Portage Biotech (Subject)
Shaw Allan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:28 PM | Portage Biotech (Subject)
Shaw Allan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024
8:41 AM | MINTZ STEVEN (Reporting)
Portage Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
10:25 AM | Bailey Gregory (Reporting)
Portage Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
11:15 PM | Portage Biotech (Filer)
| Form EFFECT | |
08/27/2024
7:30 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
5:05 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
5:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024
7:31 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024
7:00 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
4:29 PM | Portage Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
08/13/2024
7:52 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/13/2024
7:00 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024
3:31 PM | Portage Biotech (Filer)
| Form 424B3 | |
04/12/2024
4:21 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
4:22 PM | Portage Biotech (Filer)
| Form 424B3 | |
03/08/2024
4:30 PM | Portage Biotech (Filer)
| Form 424B3 | |
03/08/2024
4:04 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
8:11 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
8:36 PM | Portage Biotech (Filer)
| Form 424B3 | |
02/28/2024
4:19 PM | Portage Biotech (Filer)
| Form 424B3 | |
02/14/2024
2:50 PM | ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
| Form SC 13G | |
01/18/2024
4:09 PM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
7:10 AM | Portage Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
